FindTrial
Sign In

Comparision of surgical and endovascular treatment for aortic coarctation

A multi-center ambispective cohort study for comparision of surgical and endovascular treatment for coarctation of the aorta

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043974
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coarctation of the Aorta

Interventions

Surgical repair:Nil
Transcatheter treatment:Nil

Sponsors

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients admitted to hospital from 2009 to 2030 who are mainly diagnosed with Coarctation of Aorta. 2. The patient or guardian agrees with the participant.

Exclusion criteria

Exclusion criteria: 1. CoA with other complicated intracardiac malformation, such as aortic arch hypoplasia, hypoplastic left heart,total anomalous pulmonary venous drainage, pulmonary vein stenosis and so on. 2. Patients and guardians are not willing to participate in this study.

Design outcomes

Primary

MeasureTime frame
Death;recurrent aortic coarction;reintervention;aortic related death;—

Secondary

MeasureTime frame
Aneurysm formation;hospitalization length;peak systolic pressure gradient across the coarctation;cerebral infarction;cardiac insufficiency;—

Countries

China

Contacts

Public ContactQiang Wang

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

wq.cory@163.com13691061902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026